The Rosalind Franklin Prize is named for the molecular biologist Dr. Rosalind Franklin, who played a vital role in discovering the structure of DNA. Her life was cut short in 1958 when she died of ovarian cancer at age 37. Throughout her life she was a committed researcher; this award is presented to a senior researcher who continues Franklin’s legacy of excellence.
The Rosalind Franklin Prize for Excellence in Ovarian Cancer Research is a $10,000 annual prize awarded to an individual in recognition of his or her outstanding contributions to basic science, translational, or clinical research in ovarian cancer. Nominees should have a track record of high achievement in the field of ovarian cancer research, as demonstrated by significant contributions to the care of women with gynecologic cancer and to the literature in the field, as well as having obtained significant extramural research funding. The prize rewards past achievement and provides further incentive for an outstanding working scientist to continue to do exceptional research into the causes, prevention, and treatment of ovarian cancer.
Nominees must hold an MD, PhD, or ScD degree, and must hold an academic appointment at a non-profit medical or research institution in the USA.
Deadline: Oct. 14, 2021